Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm Metastasis × Escitalopram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Stomach Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 Depression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Bile Duct Neoplasms 1 Behavior, Addictive 1

Interventions

pembrolizumab 23 Capecitabine 21 Cyclophosphamide 20 Bevacizumab 20 Gemcitabine 18 aldesleukin 17 Fluorouracil 17 Nivolumab 16 Docetaxel 16 Leucovorin 15 Paclitaxel 14 Irinotecan 14 Radiosurgery 13 Interleukin-2 13 fludarabine 12 Oxaliplatin 12 fludarabine phosphate 10 Drug Therapy 10 Cisplatin 10 Albumin-Bound Paclitaxel 10 Cetuximab 9 Carboplatin 9 Radiotherapy 8 Everolimus 8 Doxorubicin 8 Zoledronic Acid 7 Trastuzumab 7 Temozolomide 7 Sunitinib 7 Erlotinib Hydrochloride 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04763135 2023-06-08

MIR-P

Hospices Civils de Lyon

Phase 3 Terminated

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡